13.62
price down icon7.03%   -1.03
after-market Handel nachbörslich: 13.62
loading

Finanzdaten der Erasca Inc-Aktie (ERAS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
9.39%
34.55
38.12 35.63 35.71 37.24
Operating Income/Loss
9.39%
-34.55
-38.12 -35.63 -35.71 -37.24
Nonoperating Income/Loss
7.41%
3.934
4.249 4.664 3.48 6.042
Income/Loss From Continuing Operations Before Tax
9.64%
-30.61
-33.88 -30.97 -32.23 -31.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.64%
-30.61
-33.88 -30.97 -32.23 -31.20
Net Income/Loss
9.64%
-30.61
-33.88 -30.97 -32.23 -31.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.11%
283.68
283.36 283.26 16.46 282.38
Diluted Average Shares
0.11%
283.68
283.36 283.26 16.46 282.38
Basic Earnings Per Share
8.33%
-0.11
-0.12 -0.11 -0.09 -0.11
Diluted Earnings Per Share
8.33%
-0.11
-0.12 -0.11 -0.09 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):